Who invested in Trubion Pharmaceuticals?
Trubion Pharmaceuticals's investors include Venrock, ARCH Venture Partners, Frazier Healthcare Partners, Oxford Bioscience Partners and Prospect Venture Partners, and 1 more on record.
United States · Venture startup
3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Trubion Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$56Mraised across 3 rounds since 2002, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $10M sold, first sale Sept 2009
From a historical funding record
No investor was named in the report.
From a historical funding record
From the SEC filings it signed: 5 on the team.
On the board, as filediAnders D. HoveDavid A. MannDavid SchnellLee R. BrettmanPatrick HeronSamuel R. SaksSteven Gillis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Trubion Pharmaceuticals's investors include Venrock, ARCH Venture Partners, Frazier Healthcare Partners, Oxford Bioscience Partners and Prospect Venture Partners, and 1 more on record.
Trubion Pharmaceuticals has raised $56M across 3 rounds since 2002.
Trubion Pharmaceuticals's most recent round was a Venture of $10M in Sept 2009.
Trubion Pharmaceuticals's largest round on record is $32M (Series B), in Jul 2004.
Trubion Pharmaceuticals's first round on record, in Jul 2004, was backed by Venrock, ARCH Venture Partners and Frazier Healthcare Partners and 3 others.
Trubion Pharmaceuticals's latest named round is a Venture, in Sept 2009.
Trubion Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.